key: cord-0929812-a1risvw6
authors: Theuerkauf, Samuel A.; Michels, Alexander; Riechert, Vanessa; Maier, Thorsten J.; Flory, Egbert; Cichutek, Klaus; Buchholz, Christian J.
title: Quantitative Assays Reveal Cell Fusion at Minimal Levels of SARS-CoV-2 Spike Protein and Fusion-from-Without
date: 2020-10-15
journal: bioRxiv
DOI: 10.1101/2020.10.15.340604
sha: 4d1361b1058b8a4a3a3325d95f079a68667bdfc6
doc_id: 929812
cord_uid: a1risvw6

Cell entry of the pandemic virus SARS-CoV-2 is mediated by its spike protein S. As main antigenic determinant, S protein is in focus of antibody-based prophylactic and therapeutic strategies. Besides particle-cell fusion, S mediates fusion between infected and uninfected cells resulting in syncytia formation. Here we present quantitative assay systems covering not only particle-cell and cell-cell fusion, but also demonstrating fusion-from-without (FFWO), the formation of syncytia induced by S-containing viral particles in absence of newly synthesized S protein. Based on complementation of split β-galactosidase and virus-like-particles (VLPs) displaying S protein, this assay can be performed at BSL-1. All three assays provided readouts with a high dynamic range and signal-to-noise ratios covering several orders of magnitude. The data obtained confirm the enhancing effect of trypsin and overexpression of angiotensin-converting enzyme 2 (ACE2) on membrane fusion. Neutralizing antibodies as well as sera from convalescent patients inhibited particle-cell fusion with high efficiency. Cell-cell fusion, in contrast, was only moderately inhibited despite requiring much lower levels of S protein, which were below the detection limit of flow cytometry and Western blot. The data indicate that syncytia formation as a pathological consequence in tissues of Covid-19 patients can proceed at low levels of S protein and may not be effectively prevented by antibodies.

The emergence of the so-called SARS-coronavirus-2 (SARS-CoV-2) is met with an 39 unprecedented global scientific effort. As causative agent of the pandemic and the 40 associated disease COVID-19, SARS-CoV-2 is a typical coronavirus, with a large spike 41 protein (S) inserted in the membrane of the enveloped particle. Being the main surface-42 exposed antigen and the mediator of cell entry, S protein forms the most important 43 target of current efforts to develop therapeutic drugs and prophylactic vaccines (Gioia 44 et al., 2020; Tang et al., 2020) . 45

As a typical class I viral fusion protein, S protein forms trimers with a globular head 46 domain containing the receptor-binding site which contacts angiotensin-converting 47 2020). Thus, two alternative entry routes exist for SARS-CoV-2, notably determined 64 by the availability of activating proteases (Hoffmann et al., 2020b; Tang et al., 2020) . 65

For both routes, membrane fusion is pH-independent. 66

Like other fusion proteins that are active pH-independently, S protein mediates not only 67 fusion between the viral and the cellular membranes during particle entry, but also 68 fusion of infected cells with uninfected cells. This process is mediated by newly 69 synthesized S protein accumulating at the cell surface. The resulting syncytia are giant 70 cells containing at least three, often many more nuclei. Cell-cell fusion is used by 71 viruses such as human immunodeficiency virus (HIV) (Compton and Schwartz, 2017; 72 Bracq et al., 2018) , measles virus (MV) (Griffin, 2020), or herpesvirus (Cole and Grose, 73 2003 ) to spread in a particle-independent way. The resulting syncytia are documented 74 as pathological consequence detectable in various tissues such as lung (MV), skin 75 (herpesvirus) or lymphoid tissues (HIV) . In brain, cell-to-cell transmission via 76 hyperfusogenic F proteins constitutes a hallmark of MV-caused encephalitis as a fatal 77 consequence of acute MV infections manifesting years later (Ferren et al., 2019) . 78

Besides particle-cell and cell-cell fusion, a third membrane fusion process mediated by 79 viral spike proteins has been designated fusion-from-without (FFWO) (Roller et al., demonstrate syncytia formation even at undetectable levels of S protein, and fusion-90 from-without. Examination of sera from convalescent Covid-19 patients revealed 91 potent neutralizing capacity against particle-cell fusion, but only moderate or low 92 activity against cell-cell fusion. 93

Minimal Essential Medium Eagle (Sigma, M2414) supplemented with 10% FBS, 1x L-121 glutamine, 1x non-essential amino acids (Gibco, 11140-035) and 1x sodium pyruvate 122 (Gibco, 11360-070) . MRC-5 and Calu-3 were subcultured with trypsin in EDTA-PBS 123 every two weeks at ratios between 1:2 and 1:3, medium was exchanged twice weekly. 124

For transfection of HEK-293T in T75 flasks, two mixes were prepared, each in 1 mL 125 plain DMEM High Glucose, one containing 60 µL of 18 mM TA-Trans 126 (polyethyleneimine) and the other 15 µg plasmid DNA. When the amount of S protein 127 encoding plasmid was varied, pCDNA3.1(+) was added to compensate for the overall 128 plasmid quantity. The mixtures were combined and incubated together for at least 20 129 min. Medium on cells was replaced by 4.3 mL of 1.5 x growth medium (15% FBS, 1.5 130

x L-Glutamine) and 2 mL transfection mix were added. Cells were incubated for 4-8 h 131 before medium was replaced by 10 mL of fresh growth medium. 132 133

For the production of LV particles and VLPs, we adapted our established protocol for 135 after thawing. Particle numbers were determined by nanoparticle tracking analysis 145 using the NanoSight300 system (Malvern). 146 147 Transduction and neutralization 148 2x10 4 cells/ well were seeded into flat-bottom 96-well plates in complete growth 149 medium. On the next day, 0.2 µL/well of S∆19-LV or VSV-LV stock was added in 150 complete growth medium. For neutralization, antibody and sera were incubated with 151 the vector stock at concentrations of 40 µg/ mL and 50% v/v, respectively, in a final 152 volume of 50 µL/well for 30-60 min at 37°C. Medium was aspirated from the seeded 153 cells and replaced by 50 µL/well of the transduction mix. The next morning, medium 154 was exchanged for 100 µL/well of fresh complete growth medium. Transduction 155 efficiencies were determined three days after vector addition by luminescence readout 156 of cellular galactosidase activity.

HEK-293T cells were transfected as described above, in the T75 format. Two days 170 after transfection, cells were detached by incubation in 0.25% trypsin -1 mM EDTA -171 PBS for 10-15 min. Cells were characterized with regards to count and viability using 172 the Luna-Fl cell counter and acridine orange/propidium iodide dye (Logos Bio). Cells 173 were pelleted at 300 x g for 5 min and resuspended in complete growth medium to 174 yield a cell density of 5x10 4 cells/20 µL. Cocultures were set up in V-bottom plates at 175 10 5 cells/well. Cells were pelleted (300 x g, 30 s at start) just before transfer to the 176 incubator. For FFWO, VLPs were diluted to desired concentrations in complete growth 177 medium and added to cocultures at 20 µL/well by thorough pipetting prior to the 30 s 178 centrifugation. For neutralization of FFWO, 5x10 8 particles/well were incubated with 179 antibodies or sera for 30 min in the incubator before addition to the coculture. For the 180 neutralization of particle-free cell fusion, effector cells were pre-incubated with 181 antibodies or sera in a volume of 40 µL/well (i.e. 5x10 4 cells/well) for 30 min in the 182 incubator, retaining the inhibitor concentrations specified above. After pre-incubation, 183 effector cells were mixed with target cells in a total culture volume of 60 µL/well. Luminescense data and flow cytometry MFIs were assumed to be lognormally 243 distributed. Accordingly, tests were performed on log-transformed data which were 244 assumed to be normally distributed. Data generated from the same batch of 245 transfected cells (i.e. from the same biological replicate) were handled as matched data. For all repeated measures tests, sphericity was assumed. For particle and 247 inhibitor titrations, five-parameter asymmetric sigmoidal curves were fitted to the data. 248

If not otherwise indicated, symbols represent means of technical triplicates, bars 249 represent means (geometric means for non-log-transformed data) of biological 250 replicates and error bars represent 95 % CIs. Differences of population means were 251 quantified by repeated measures 2-way ANOVA (one-way ANOVA, where indicated) 252 on log-transformed data and Tukey's multiple comparisons test. Select multiplicity-253 adjusted p-values are reported. 254

Results 256

Spike protein mediated particle entry 257

To follow particle entry mediated by S protein, we set out to generate potent lentiviral 258 vectors (LVs) pseudotyped with S protein to set up an assay with a high signal-to-noise 259 ratio. Codon-optimized S protein, full length or carrying the previously described C-260 terminal truncation (SΔ19), were used for pseudotyping (Ou et al., 2020) . Upon transfection, SARS-CoV-2 S protein showed a remarkable fusogenic activity. 279

When transfected HEK-293T cells producing SΔ19-LV were detached and cocultured 280 in a 1:1 ratio with Vero E6 cells, plates were covered by large syncytia, each containing at least 10, and, up to 100 nuclei, formed overnight (Suppl. Fig. 1A ). To examine this 282 further, the full-length and truncated forms of S were overexpressed in HEK-293T and 283 cocultures with Vero E6 target cells were imaged by confocal laser scanning 284 microscopy (Suppl. Fig. 1B) . Both, S and SΔ19 protein, induced many large syncytia 285 characterized by cytoskeletal rearrangement, clustering of more than five nuclei and 286 colocalization of the RFP and GFP reporter dye signals (Suppl. Fig. 1C ). 287

To quantify the cell-cell fusion mediated by S protein, an α-complementation assay 288 based on β-galactosidase previously used to evaluate HIV-mediated fusion (Holland 289 et al., 2004) was adapted to the S protein. Upon cell-cell fusion, complementation 290 inside the syncytium results in active enzyme that can be quantified by converting 291 substrate in a luminescence reaction ( Fig. 2A) . In a first step, the minimal amount of S 292 protein required to result in a detectable signal was determined. Effector cells were 293 transfected with varying quantities of S protein encoding plasmid ranging and S protein 294 surface expression was followed by flow cytometry. S protein expression was still 295 clearly detectable with 75 ng of plasmid, while the mean fluorescence intensity (MFI) 296 at 7.5 ng plasmid was indistinguishable from background ( Fig. 2B) . Notably, this low 297 level of S protein was still sufficient to induce significant cell-cell fusion, when the assay 298 was allowed to proceed over-night, highlighting the potent fusogenic activity of S 299 protein (Fig. 2C) . With higher amounts of plasmid, three hours incubation were 300 sufficient to obtain signals more than 10-fold above background. Interestingly, when 301 cells were detached prior to coculture with EDTA only instead of trypsin-EDTA, the cell 302 fusion activity decreased by at least one order of magnitude, and only overnight 303 incubation yielded signals significantly over background (Fig. 2D ). When target cells 304 overexpressed ACE2 and were detached with trypsin, the maximum extend of the 305 fusion signal increased by another order of magnitude (Fig. 2D) . Now, the signal-to-306 noise ratio reached two orders of magnitude already after one hour incubation including the samples expressing the lowest amounts of S protein. This highlights the 308 dependence of S protein activity on the presence of ACE2. Under optimal conditions 309 and with ACE2 overexpressing cells, a signal-to-noise ratio of 2.8 orders of magnitude 310 was reached. 311 312

To examine whether S protein present on the surface of viral particles can mediate 314 FFWO, we generated LV-based virus-like-particles (VLPs) having the SΔ19 protein 315 incorporated. Western blot analysis confirmed that similar levels of SΔ19 protein were 316 present in VLPs and SΔ19-LV particles (Fig. 4E) . To quantify FFWO, cocultures of 317 293T-ACE2 cells transfected with the plasmids encoding the alpha or the omega 318 fragment of β-galactosidase were incubated with different amounts of VLPs to induce 319 cell fusion and thus complementation (Fig. 3A) . At a dose of 5000 VLPs per cell, a 320 substantial fusion signal more than one order of magnitude over background was 321 obtained (Fig. 3B ). This signal increased further with increasing particle numbers, 322 reaching a plateau at 5x10 4 particles per cell, with a signal-to-noise ratio of 2.7 orders 323 of magnitude (Fig. 3B ). This FFWO activity of the S protein was again strongly 324 dependent on ACE2 overexpression since no significant fusion activity was observed 325 in absence of ACE2 (Suppl. Fig. 2) . When the VLPs were treated with 2 mg/mL trypsin, 326 the fusion signal increased by approximately 5.7-fold after 30 min of incubation. The 327 chosen incubation period was critical for this increase, since prolonged incubation with 328 trypsin was not beneficial (Fig. 3C) . This correlated well with processing of the S0 329 protein into S2 for short trypsin exposure while prolonged digestion resulted in loss of 330 S2 (Fig. 3D) . 331

Having established three different quantitative assays systems with an extraordinary 334 high signal-to-noise ratio, we next assessed the neutralizing capacity of an S protein 335 specific antibody, as well as convalescent sera from two donors. The sera were 336 obtained four months after diagnosis of the infection with SARS-CoV-2 by PCR. Both 337 donors had experienced mild symptoms. The strongest neutralization was observed in 338 the particle entry assay. Addition of a neutralizing monoclonal anti-S antibody reduced 339 the reporter signal by 2.3 orders of magnitude, which corresponded to more than 99% 340 neutralization ( Fig. 4A; Suppl. Fig. 3 ). Both sera reduced the reporter activity by 2.0 341 (98.5%) and 1.7 (97.4%) orders of magnitude, respectively, compared to control serum 342 ( Fig. 4A; Suppl. Fig. 3 ). In sharp contrast, their effect on cell-cell fusion remained below 343 one order of magnitude for all three inhibitors (α-S AB: 0.4 orders (60.8%); serum 81: 344 0.5 orders (71.0%)); serum 82: 0.7 orders (79.1%)), even though the signal-to-345 background ratio was comparable for both assays ( Fig. 4B; Suppl. Fig. 3 ). For the 346 inhibition of FFWO, a mixed picture was obtained. The monoclonal anti-S antibody 347 decreased FFWO signal by 1.7 orders of magnitude to background level (97.9% 348 neutralization) (Fig. 4C) . Titration of the antibody yielded an IC50 of 0.37 μg/mL, well 349 in line with the value determined by the vendor in pseudovirus neutralization assays 350 (0.11 μg/mL) (Fig. 4D) . The effect of the patient sera was clearly less pronounced than 351 what was observed in particle entry neutralization. The strongest effect was seen with 352 serum 82 which decreased the fusion signal by 1.2 orders of magnitude (94% 353 neutralization). Serum 81, which was highly active in the entry assay had no stronger 354 effect on the fusion signal than the control serum (0.5 orders of magnitude, 72% 355 neutralization) (Fig. 4C-D) . Notably, antigen amounts on SΔ19-LV particles and the 356 corresponding VLPs were similar, while a higher dose of S was used in the FFWO They exceeded the amounts of S protein present in the cell-cell fusion assay by far, 359 thus excluding higher amounts of antigen in the cell-cell fusion assay as causative for 360 this difference. 361 362

Here we provide novel assay systems for a systematic side-by-side comparison of the 365 membrane fusion activities of the SARS-CoV-2 spike protein S. Three quantitative 366 assays are presented, covering i) entry of LV particles pseudotyped with S, ii) fusion 367 between S and ACE2 expressing cells and iii) fusion between ACE2 expressing cells 368 via VLPs displaying S protein. All assays exhibit high signal-to-noise ratios covering 369 two to three orders of magnitude as important prerequisite to identify subtle differences, (Ou et al., 2020; Zhu et al., 381 2020 ). The assay system we describe here improves upon the previously reported 382 maximum signal-to-noise ratios by at least an order of magnitude (Zhu et al., 2020) . 383

The syncytia forming activity of the S protein is remarkable not only with respect to 384 speed and extent, but even more so with respect to the low amounts of S protein 385 required, even when ACE2 is not overexpressed on the target cells. The high sensitivity 386 of the assay we established here allowed the detection of cell fusion activity at levels 387 of S protein which were below the level of detection of flow cytometry and Western receptor ACE2 (Shang et al., 2020b )(Walls et al., 2020 . Being well in the low 390 nanomolar range, it is even lower than that of the highly fusogenic MV for its receptors 391 (Navaratnarajah et al., 2008; Mühlebach et al., 2011) . 392

To our knowledge, we here provide the first demonstration of FFWO not only for the 393 SARS-CoV-2 S protein but for any coronavirus, while FFWO has been observed for 394 other enveloped viruses entering cells by pH-independent membrane fusion, such as 395 retroviruses (Clavel and Charneau, 1994 ), paramyxoviruses (Bratt and Gallaher, 1969 ) 396 and herpesviruses (Falke et al., 1985 . While it is conceivable that high concentrations 397 of virus particles may accumulate in certain organs of infected patients, clear evidence 398 for a pathogenic relevance of FFWO in patients has yet to be provided, although some 399 evidence from animal studies exists for retroviruses (Murphy and Gaulton, 2007) . 400

Independently of that, the FFWO assay described here can become a prime choice for 401 the preclinical evaluation of neutralizing binders for the following reasons: First, it can 402 be performed at BSL-1 conditions, while LV-based assays require BSL-2. Second, it 403 exhibits a high signal-to-noise ratio, even exceeding the maximum ratio recently 404 reported for a benchmark LV-based neutralization assay (Zeng et al., 2020) . Third, this 405 assay is unique in combining neutralization of particle-associated S protein with 406 neutralization of cell fusion, thus providing information about two mechanisms of 407 infection in a single readout. 408 Syncytia formation has recently been described as main and unique lung pathology in 409 patients affected with Covid-19 in an occurrence not seen in other lung infections 410 before. The polynucleated pneumocytes detected by histology and immunostaining 411 were virus positive and expressed spike protein (Giacca et al., 2020) . Especially in 412 persistent virus infections, syncytia formation is an important mechanism of virus 413 spread as described for other important human pathogens like MV (Ferren et al., 2019) 414 or various herpesviruses (Cole and Grose, 2003) . The low level of S protein sufficient for cell fusion we determined here appears to be ideal to support persistence of SARS-416

CoV-2. Evidence for SARS-CoV-2 persistence including neurological complications is 417 recently accumulating and it is particularly the persistence which appears to result in 418 fatal outcomes (Hamming et al., 2004; Berger, 2020) . In this respect, it may be worrying 419 that the antibodies and convalescent sera we tested were less efficient in neutralizing 420 cell-cell fusion than particle entry, even more so since the amounts of S protein present 421 in the latter assay were substantially higher. This suggests that cell fusion is not only 422 proceeding with minimal amounts of S protein, but also difficult to access for 423 neutralizing antibodies. Further studies assessing sera from many more patients 424 including severe and fatal cases will have to be performed to investigate this 425 hypothesis further. The biological assay systems required are now available. Sciences of the United States of America, 117(21), 11727-11734. Available at: 548 doi:10.1073/pnas.2003138117. 549 Shang, J., Ye, G., Shi, K., Wan, Y., Luo, C. and Aihara, H. et al. (2020b) Structural 550 basis of receptor recognition by 581(7807), [221] [222] [223] [224] Available at: doi:10.1038/s41586-020-2179-y. 552

Tang, T., Bidon, M., Jaimes, J.A., Whittaker, G.R. and Daniel, S. (2020) Coronavirus 553 membrane fusion mechanism offers a potential target for antiviral development. 554 Antiviral Research, 178, 104792. Available at: doi:10.1016 /j.antiviral.2020 .104792. 555 Walls, A.C., Park, Y.-J., Tortorici, M.A., Wall, A., McGuire, A.T. and Veesler, D. 556 (2020 

A) Principle of the assay. HIV-1 derived SΔ19-VLPs were added as effector triggering 623 fusion from without (FFWO) of cocultures of ACE2 overexpressing HEK-293T cells 624 transfected with plasmids encoding the α-fragment or the ω-fragment of β-625

Cocultures were lysed and galactosidase activity of the lysates 626 determined in luminescence reactions. (B) The indicated numbers of SΔ19-VLPs or 627 bald VLP

Effect of proteolytic processing on the induction of FFWO

VLPs or no VLPs were incubated in 2 mg/mL trypsin for the indicated time periods 631 before addition to cocultures (10 5 cells). Luminescence was quantified after overnight 632 cultivation. (C). Bars represent means of technical triplicates ± 95% CIs

Processing of the S protein after trypsin treatment of the VLPs for indicated times by 634 Western blotting for S and p24 proteins

 et al. (2020) Persistence of viral RNA, widespread thrombosis and abnormal 483 cellular syncytia are hallmarks of COVID-19 lung pathology. 484 Gioia, M., Ciaccio, C., Calligari, P., Simone, G. de, Sbardella, D. and Tundo, G. et al. 485 (2020)